SINGLE VERSUS CUSTOMIZED TREATMENT PLANNING FOR IMAGE-GUIDED HIGH-DOSE-RATE BRACHYTHERAPY FOR CERVICAL CANCER: DOSIMETRIC COMPARISON AND PREDICTING FACTOR FOR ORGANS AT RISK OVERDOSE WITH SINGLE PLAN APPROACH

被引:7
作者
Chi, Alexander [1 ]
Gao, Mingcheng [1 ]
Sinacore, James [2 ]
Nguyen, Nam P. [3 ]
Vali, Faisal [1 ]
Albuquerque, Kevin [1 ]
机构
[1] Loyola Univ, Med Ctr, Dept Radiat Oncol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA
[3] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 01期
关键词
Customized planning; image guidance; brachytherapy; cervical cancer; reoptimization; INTRACAVITARY BRACHYTHERAPY; UTERINE CERVIX; WORKING GROUP; COMPUTED-TOMOGRAPHY; VOLUME PARAMETERS; RATE TANDEM; CARCINOMA; RECTUM; RECOMMENDATIONS; APPLICATOR;
D O I
10.1016/j.ijrobp.2009.03.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the dose distribution between customized planning (CP) and adopting a single plan (SP) in multifractionated high-dose-rate brachytherapy and to establish predictors for the necessity of CP in a given patient. Methods and Materials: A total of 50 computed tomography-based plans for 10 patients were evaluated. Each patient had received 6 Gy for five fractions. The clinical target volume and organs at risk (i.e., rectum, bladder, sigmoid, and small bowel) were delineated on each computed tomography scan. For the SP approach, the same dwell position and time was used for all fractions. For the CP approach, the dwell position and time were reoptimized for each fraction. Applicator position variation was determined by measuring the distance between the posterior bladder wall and the tandem at the level of the vaginal fornices. Results: The organs at risk D(2cc) (dose to 2 cc volume) was increased with the SP approach. The dose variation was statistically similar between the tandem and ring and tandem and ovoid groups. The bladder D(2cc) dose was 81.95-105.42 Gy(2) for CP and 82.11-122.49 Gy(2) for SP. In 5 of the 10 patients, the bladder would have been significantly overdosed with the SP approach. The variation of the posterior bladder wall distance from that in the first fraction was correlated with the increase in the bladder D(2cc) (SP/CP), with a correlation coefficient of -0.59. Conclusion: Our results support the use of CP instead of the SP approach to help avoid a significant overdose to the bladder. This is especially true for a decrease in the posterior wall distance of >= 0.5 cm compared with that in the first fraction. (c) 2009 Elsevier Inc.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 23 条
[1]  
Bahena JH, 1998, INT J RADIAT ONCOL, V41, P13
[2]   The role of MR imaging in invasive cervical carcinoma [J].
Boss, EA ;
Barentsz, JO ;
Massuger, LFAG ;
Boonstra, H .
EUROPEAN RADIOLOGY, 2000, 10 (02) :256-270
[3]   Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38 [J].
Datta, NR ;
Kumar, S ;
Das, KJM ;
Pandey, CM ;
Halder, S ;
Ayyagari, S .
RADIOTHERAPY AND ONCOLOGY, 2001, 60 (01) :15-24
[4]   Image-guided cervix high-dose-rate brachytherapy treatment planning: Does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk? [J].
Davidson, Melanie T. M. ;
Yuen, Jasper ;
D'Souza, David P. ;
Batchelar, Deidre L. .
BRACHYTHERAPY, 2008, 7 (01) :37-42
[5]   Cervical tumor control evaluated with ICRU 38 reference volumes and integrated reference air kerma [J].
Grigsby, PW ;
Williamson, JF ;
Chao, KSC ;
Perez, CA .
RADIOTHERAPY AND ONCOLOGY, 2001, 58 (01) :19-23
[6]   ANATOMIC VARIATION OF GYNECOLOGIC BRACHYTHERAPY PRESCRIPTION POINTS [J].
GRIGSBY, PW ;
GEORGIOU, A ;
WILLIAMSON, JF ;
PEREZ, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03) :725-729
[7]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[8]   Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations [J].
Hellebust, TP ;
Dale, E ;
Skjonsberg, A ;
Olsen, DR .
RADIOTHERAPY AND ONCOLOGY, 2001, 60 (03) :273-280
[9]  
Jones Nathan D, 2004, Brachytherapy, V3, P120, DOI 10.1016/j.brachy.2004.07.001
[10]   Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer [J].
Kirisits, C ;
Pötter, R ;
Lang, S ;
Dimopoulos, J ;
Wachter-Gerstner, N ;
Georg, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03) :901-911